"Sarcopenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Descriptor ID |
D055948
|
| MeSH Number(s) |
C10.597.613.612.500 C23.300.070.500.500 C23.888.592.608.612.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sarcopenia".
Below are MeSH descriptors whose meaning is more specific than "Sarcopenia".
This graph shows the total number of publications written about "Sarcopenia" by people in this website by year, and whether "Sarcopenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 1 | 5 |
| 2020 | 3 | 1 | 4 |
| 2021 | 5 | 0 | 5 |
| 2022 | 4 | 0 | 4 |
| 2023 | 5 | 0 | 5 |
| 2024 | 1 | 1 | 2 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcopenia" by people in Profiles.
-
Comparing the performance of 3 sarcopenia definitions for predicting adverse events prior to liver transplant. Hepatol Commun. 2025 Jun 01; 9(6).
-
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial. J Cachexia Sarcopenia Muscle. 2025 Apr; 16(2):e13750.
-
Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study. Clin Transplant. 2024 Dec; 38(12):e70034.
-
Investigating the effects of synbiotic supplementation on functional movement, strength and muscle health in older Australians: a study protocol for a double-blind, randomized, placebo-controlled trial. Trials. 2024 May 07; 25(1):307.
-
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management. World J Gastroenterol. 2023 Dec 14; 29(46):6028-6048.
-
Malnutrition, sarcopenia, and frailty assessment in pediatric transplantation. Nutr Clin Pract. 2024 Feb; 39(1):27-44.
-
Indices of sarcopenic obesity are important predictors of finite element analysis-derived bone strength in older adults with obesity. Front Endocrinol (Lausanne). 2023; 14:1279321.
-
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease. Hepatol Commun. 2023 11 01; 7(11).
-
Identification of three bacterial species associated with increased appendicular lean mass: the HUNT study. Nat Commun. 2023 04 20; 14(1):2250.
-
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022. Clin Nutr. 2023 05; 42(5):687-699.